Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.

Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.

Publication date: Sep 21, 2023

Low and persistent levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA/protein/virus can be detected in clinical samples months after infection, possibly related to the emergence of SARS-CoV-2 variants or development of long coronavirus disease. Here, we present a protocol to detect low levels of viral RNA together with protein using flow cytometry and microscopy. We describe steps for cell infection with SARS-CoV-2 and quantification by fluorescence in situ hybridization-flow cytometry. We then detail procedures for visualization using immunolabeling and RNAscope. This approach is directly applicable to clinical samples. For complete details on the use and execution of this protocol, please refer to Zhu et al. (2022). .

Open Access PDF

Concepts Keywords
Clinical Cell Biology
Coronavirus Health Sciences
Months Immunology
Rna Microbiology
Microscopy
Molecular Biology

Original Article

(Visited 1 times, 1 visits today)